Canary

Executive Summary — Environmental Health Testing for Healthcare Platforms

The Problem

70% of allergy/asthma triggers are home-based (EPA)
Patients leave the booking platform to find inspectors on Angi/Yelp — no clinical trust, no HSA path
$14.5B residential testing market completely disconnected from healthcare

Indoor Air Quality & Mold — spore traps, VOC panels, particulate counts ($300–600)
Water Quality — lead, PFAS, bacteria, endocrine disruptors ($150–500)
Allergen Mapping — room-by-room profiling, HVAC assessment ($400–800)
Radon Testing — 2nd leading cause of lung cancer; 1 in 15 homes above action level ($150–250)
Lead Safety — paint + water + soil; HSA-eligible per IRS Pub 502 ($300–700)
Ergonomic Assessment — home office, musculoskeletal risk; 60M+ remote workers ($200–500)
Combustion Gas Testing — gas stove NO2/CO/methane; first-mover category ($200–400)
Post-visit nudge + HSA/FSA unlock via automated LMN (~30% patient savings)
Testing is the wedge; remediation referrals are 5–20x the testing revenue

$20M Year 1 → $60M Y2 → $120M Y3 → $500M+ Y5
$256 blended revenue per inspection across 4 stacked layers
$5B+ valuation at Year 5 (10–15x ARR, health-tech SaaS multiples)
1,175+ licensed inspectors identified in NYC metro alone — outreach-ready
6 revenue streams: marketplace, insurer-sponsored, UK housing, corporate wellness, data licensing, B2G
Three enterprise contracts in Year 1: employer pilot M3 ($2M) + UK housing M5 ($3M) + insurer M6 ($10M)